Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer.
Cancer Biother Radiopharm
; 32(5): 176-183, 2017 Jun.
Article
in En
| MEDLINE
| ID: mdl-28622037
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Terapias_biologicas
/
Aromoterapia
Main subject:
Phenylurea Compounds
/
Thyroid Neoplasms
/
Niacinamide
/
Proto-Oncogene Proteins c-akt
/
TOR Serine-Threonine Kinases
/
Antineoplastic Agents
Language:
En
Journal:
Cancer Biother Radiopharm
Year:
2017
Type:
Article